Sanofi Genzyme has its expansive sights set on a new tech campus in Cambridge — report

Sanofi Genzyme has reared its head again in the booming commercial real estate market in and around Cambridge, MA. 

The Boston Globe reports that the French giant’s US arm is in the market for 400,000 square feet of space to house some 2,000 staffers. And the local daily’s news sources are putting their money on Cambridge Crossing, the sprawling campus project now being built on a former rail yard.